Comparative study of topical 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT) and surgery for the treatment of high-grade vaginal intraepithelial neoplasia

医学 光动力疗法 外科 外科切除术 活检 临床疗效 宫颈上皮内瘤变 内科学 宫颈癌 癌症 化学 有机化学
作者
Yingcui Zhang,Yuehui Su,Yujie Tang,Lihong Qin,Yan Shen,Bingjie Wang,Mengjiao Zhou,Yingying Zhou,Lili Cao,Ting Zhang,Mengzhen Zhang
出处
期刊:Photodiagnosis and Photodynamic Therapy [Elsevier BV]
卷期号:39: 102958-102958 被引量:14
标识
DOI:10.1016/j.pdpdt.2022.102958
摘要

To compare the clinical efficacy and safety of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) and local surgical excision in the treatment of high-grade vaginal intraepithelial neoplasia (VAIN).This was a retrospective study of a single center. Patients with biopsy-proven high-grade VAIN were counseled on the option of excision or ALA-PDT. After treatment patients were followed up at 3, 6 and 12 months and every 6 months afterwards. Clinical data of two groups were analyzed.Sixty patients were treated with ALA-PDT and 40 patients underwent excision surgery. The clinical characteristics of patients in the two groups were similar. The mean ages of patients treated with ALA-PDT and local surgical excision were 41.93+13.08 (18-70) and 43.25+11.64 (22-61) years old, respectively. The treatment times of PDT for patients in the ALA-PDT group were 5.48±1.41 (2-8) times. At 3-6 months after treatment, the overall complete remission (CR) rate was 93.33% (56/60) in PDT group and 82.5% (33/40) in local surgical excision group. In PDT group, a 12- and 24-month follow-up, the total HPV clearance rate was 68.97% and 77.55%, respectively. At 12-month and 2-year follow-up after local surgical excision, the total HPV clearance rate was 60% and 64.52%, respectively. Further analysis showed that the clinical efficacy was comparable between the two treatments. Patients over 45 years old exhibited a lower HPV clearance rate (P<0.05) than those under 45 years old. It was also observed that persistent HPV infection is a major risk factor for persistent disease. Further comparative analyses showed no significant difference in the CR rate and treatment times between VAINII and VAINIII in ALA-PDT group. Moreover, 4 patients (11.36%) developed recurrent lesions during follow-up after ALA-PDT, whereas 3 patients (8.33%) in the local excision group developed recurrent lesions. In addition, there was no significant difference in the recurrent rate between two groups.ALA-PDT shows similar efficacy and less side effects compared to local surgical excision.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
懒猫完成签到,获得积分10
2秒前
冰冰宝发布了新的文献求助10
5秒前
清秀的懿轩完成签到 ,获得积分10
6秒前
12秒前
Kai完成签到,获得积分10
13秒前
owoow完成签到 ,获得积分10
14秒前
冰冰宝完成签到,获得积分10
17秒前
碧蓝丹烟完成签到 ,获得积分10
18秒前
noss发布了新的文献求助10
18秒前
圣泽同学完成签到,获得积分10
19秒前
九零后无心完成签到,获得积分10
28秒前
古炮发布了新的文献求助50
30秒前
mia完成签到,获得积分10
36秒前
发嗲的慕蕊完成签到 ,获得积分10
44秒前
行走的绅士完成签到,获得积分10
47秒前
凶狠的盛男完成签到 ,获得积分10
49秒前
jeffrey完成签到,获得积分10
57秒前
1分钟前
小木发布了新的文献求助10
1分钟前
tonydymt完成签到 ,获得积分10
1分钟前
FashionBoy应助无奈的萍采纳,获得10
1分钟前
zokor完成签到 ,获得积分10
1分钟前
MADAO完成签到 ,获得积分10
1分钟前
yhbk完成签到 ,获得积分10
1分钟前
路过完成签到 ,获得积分10
1分钟前
1分钟前
momo发布了新的文献求助10
1分钟前
SC完成签到 ,获得积分10
1分钟前
兔兔完成签到 ,获得积分10
1分钟前
Shining_Wu发布了新的文献求助10
1分钟前
康康舞曲完成签到 ,获得积分10
1分钟前
CooL完成签到 ,获得积分10
1分钟前
开放访天完成签到 ,获得积分10
1分钟前
猪猪hero应助科研通管家采纳,获得10
2分钟前
佰斯特威应助科研通管家采纳,获得10
2分钟前
夜白应助科研通管家采纳,获得20
2分钟前
猪猪hero应助科研通管家采纳,获得10
2分钟前
2分钟前
小李老博完成签到,获得积分10
2分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
Mixing the elements of mass customisation 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3779247
求助须知:如何正确求助?哪些是违规求助? 3324813
关于积分的说明 10220009
捐赠科研通 3039964
什么是DOI,文献DOI怎么找? 1668526
邀请新用户注册赠送积分活动 798714
科研通“疑难数据库(出版商)”最低求助积分说明 758503